Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis.

Stojadinovic A, Hoos A, Nissan A, Dudas ME, Cordon-Cardo C, Shaha AR, Brennan MF, Singh B, Ghossein RA.

Hum Pathol. 2003 Jan;34(1):54-64.

PMID:
12605367
2.

Oxyphil parathyroid carcinomas: a clinicopathologic and immunohistochemical study of 10 cases.

Erickson LA, Jin L, Papotti M, Lloyd RV.

Am J Surg Pathol. 2002 Mar;26(3):344-9.

PMID:
11859206
3.

Defining a molecular phenotype for benign and malignant parathyroid tumors.

Fernandez-Ranvier GG, Khanafshar E, Tacha D, Wong M, Kebebew E, Duh QY, Clark OH.

Cancer. 2009 Jan 15;115(2):334-44. doi: 10.1002/cncr.24037.

4.

Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis.

Stojadinovic A, Brennan MF, Hoos A, Omeroglu A, Leung DH, Dudas ME, Nissan A, Cordon-Cardo C, Ghossein RA.

Mod Pathol. 2003 Aug;16(8):742-51.

5.

The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors.

Vargas MP, Vargas HI, Kleiner DE, Merino MJ.

Mod Pathol. 1997 Jan;10(1):12-7.

PMID:
9021722
6.

Analysis of parathyroid neoplasms by interphase fluorescence in situ hybridization.

Erickson LA, Jalal SM, Harwood A, Shearer B, Jin L, Lloyd RV.

Am J Surg Pathol. 2004 May;28(5):578-84.

PMID:
15105644
7.

Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.

Erickson LA, Jin L, Goellner JR, Lohse C, Pankratz VS, Zukerberg LR, Thompson GB, van Heerden JA, Grant CS, Lloyd RV.

Mod Pathol. 2000 Feb;13(2):186-92.

8.

Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein.

Erickson LA, Jin L, Wollan P, Thompson GB, van Heerden JA, Lloyd RV.

Am J Surg Pathol. 1999 Mar;23(3):288-95.

PMID:
10078919
9.

Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.

Hoos A, Stojadinovic A, Singh B, Dudas ME, Leung DH, Shaha AR, Shah JP, Brennan MF, Cordon-Cardo C, Ghossein R.

Am J Pathol. 2002 Jan;160(1):175-83.

10.

Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma.

Haven CJ, van Puijenbroek M, Karperien M, Fleuren GJ, Morreau H.

J Pathol. 2004 Jan;202(1):86-94.

PMID:
14694525
11.

p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.

Takei K, Watanabe H, Itoi T, Saito T.

Pathol Int. 1996 Nov;46(11):908-17.

PMID:
8970203
12.

p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.

Takei K, Watanabe H, Itoi T, Saito T.

Pathol Int. 1996 Jun;46(6):426-35. Corrected and republished in: Pathol Int. 1996 Nov;46(11):908-17.

PMID:
8869994
13.

Flow cytometric DNA analysis of parathyroid tumors with special reference to its diagnostic and prognostic value in parathyroid carcinoma.

Obara T, Fujimoto Y, Hirayama A, Kanaji Y, Ito Y, Kodama T, Ogata T.

Cancer. 1990 Apr 15;65(8):1789-93.

14.

Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.

Martins AC, Cologna AJ, Tucci S Jr, Suaid HJ, Falconi RA.

J Urol. 2005 Jun;173(6):2138-42.

PMID:
15879867
15.

Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.

Strong VE, Kennedy T, Al-Ahmadie H, Tang L, Coleman J, Fong Y, Brennan M, Ghossein RA.

Surgery. 2008 Jun;143(6):759-68. doi: 10.1016/j.surg.2008.02.007. Epub 2008 Apr 14.

PMID:
18549892
16.

DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas.

Iino K, Sasano H, Yabuki N, Oki Y, Kikuchi A, Yoshimi T, Nagura H.

Mod Pathol. 1997 Sep;10(9):901-7.

PMID:
9310953
17.

p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.

Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr.

Neurosurgery. 1996 Apr;38(4):765-70; discussion 770-1.

PMID:
8692397
18.

Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases.

Bergero N, De Pompa R, Sacerdote C, Gasparri G, Volante M, Bussolati G, Papotti M.

Hum Pathol. 2005 Aug;36(8):908-14.

PMID:
16112008
19.

Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.

Filippella M, Galland F, Kujas M, Young J, Faggiano A, Lombardi G, Colao A, Meduri G, Chanson P.

Clin Endocrinol (Oxf). 2006 Oct;65(4):536-43.

PMID:
16984249
20.

Nuclear markers (star volume, mitotic index, AgNOR and Ki-67) of the primary tumor and its metastasis in non-small cell lung carcinomas.

Matheus RS, Bernardi Fdel C, Gallo CP, da Silva AP, Rodrigues OR, Capelozzi M, Lopes A, Fenezelian S, Saldiva PH, Capelozzi VL.

Pathol Res Pract. 2004;200(1):13-23.

PMID:
15157046

Supplemental Content

Support Center